Neurog3 also activated the Wnt9a gene in non-pancreatic cell contexts such as teratocarcinoma P19 cells and 3T3 fibroblasts (Supplementary Fig. S1), thus supporting the sufficiency of Neurog3 to increase Wnt9a expression in vitro. This evidence concerns the gene WNT9A and teratocarcinoma.